The investment, which is approaching KSh 1 billion (US$7.7 million), is expected to reduce the distance patients travel to access specialist ophthalmic services.
The partnership between KUTRRH and MTRH is expected to continue supporting the development of specialised renal services in Kenya.
Supported by LivaNova, the achievement expands the range of advanced neurological treatments available at the Level Six referral hospital in Kisumu.
The investments will focus on improving primary healthcare, expanding access to essential services and strengthening the country’s ability to respond to public health emergencies.
The partners are now strengthening the programme to increase access to complex neurosurgical procedures while building local capacity to provide specialist care.
The GPP Guidelines set out standards for key pharmacy services, including the sourcing and storage of medicines, prescription assessment, accurate dispensing, patient counselling, confidentiality and record keeping.
MTRH Chief Executive Officer Dr. Philip Kirwa welcomed the Pfizer delegation and highlighted the importance of partnerships with global pharmaceutical companies in supporting the hospital’s efforts to improve patient care.
Unlike conventional open surgery, the technique allows surgeons to perform the procedure through small incisions using specialised instruments controlled from a surgical console.
Jhpiego will align its reproductive, maternal and newborn health programmes with the EWENE agenda, initially focusing on 18 priority counties identified by the Government.
The technology, DoseMonitor®, connects with the hospital’s imaging equipment to automatically capture data on the amount of radiation used during procedures.